Search

Fumitaka Hayashi

from Saddle River, NJ
Age ~52

Fumitaka Hayashi Phones & Addresses

  • 45 Fox Hedge Rd, Saddle River, NJ 07458 (862) 222-0295
  • 89 Squantum St, Quincy, MA 02171
  • North Quincy, MA
  • 1109 146Th St, Seattle, WA 98155 (206) 366-1927
  • Shoreline, WA
  • 14 Beechwood Ln, Butler, NJ 07405 (973) 527-3372
  • Kinnelon, NJ
  • Morristown, NJ
  • Wakefield, MA
  • Los Angeles, CA
  • Winnetka, CA
  • Brookline, MA
  • 45 Fox Hedge Rd, Saddle River, NJ 07458

Work

Company: BETH ISRAEL MEDICAL CENTER Address: 10 Nathan D Perlman Pl, New York, NY 10003 Phones: (212) 420-4111 (212) 420-2028

Education

School / High School: University of Medicine And Dentistry of New Jersey / Newark 2010

Languages

English

Industries

Mental Health Care

Specialities

Psychiatry

Professional Records

Medicine Doctors

Fumitaka Hayashi Photo 1

Dr. Fumitaka Hayashi, New York NY - MD (Doctor of Medicine)

View page
Specialties:
Psychiatry
Address:
10 Nathan D Perlman Pl Suite 2Nd, New York, NY 10003

BETH ISRAEL MEDICAL CENTER
10 Nathan D Perlman Pl, New York, NY 10003
(212) 420-4111 (Phone), (212) 420-2028 (Fax)
Languages:
English
Education:
Medical School
University of Medicine And Dentistry of New Jersey / Newark
Graduated: 2010
Fumitaka Hayashi Photo 2

Fumitaka Hayashi

View page

Resumes

Resumes

Fumitaka Hayashi Photo 3

House Staff

View page
Industry:
Mental Health Care
Work:
Beth Israel Medical Center
House Staff

Publications

Us Patents

Toll-Like Receptor 5 Ligands And Methods Of Use

View page
US Patent:
7915381, Mar 29, 2011
Filed:
Apr 17, 2002
Appl. No.:
10/125692
Inventors:
Alan Aderem - Seattle WA, US
Fumitaka Hayashi - North Quincy MA, US
Kelly D. Smith - Seattle WA, US
David M. Underhill - Seattle WA, US
Adrian Ozinsky - Seattle WA, US
Assignee:
Institute for Systems Biology - Seattle WA
University of Washington - Seattle WA
International Classification:
A61K 48/00
A61K 39/02
A61K 31/715
C12N 9/00
US Classification:
530350, 4242341, 435 72, 435183, 514 54
Abstract:
The invention provides an immunomodulatory flagellin peptide having at least about 10 amino acids of substantially the amino acid sequence GAVQNRFNSAIT (SEQ ID NO:2), or a modification thereof, and having toll-like receptor 5 (TLR5) binding. Methods of inducing an immune response are also provided.

Toll-Like Receptor 5 Ligands And Methods Of Use

View page
US Patent:
20050147627, Jul 7, 2005
Filed:
Nov 16, 2004
Appl. No.:
10/991347
Inventors:
Alan Aderem - Seattle WA, US
Fumitaka Hayashi - Kinnelon NJ, US
Kelly Smith - Seattle WA, US
David Underhill - Seattle WA, US
Adrian Ozinsky - Seattle WA, US
International Classification:
A61K039/02
C12N009/00
C07K014/195
US Classification:
424242100, 435183000, 530350000
Abstract:
The invention provides an immunomodulatory flagellin peptide having substantially the same amino acid sequence GALNEINNNLQRVRELAVQSANSTNSQSDLDSIQAEITQ (SEQ ID NO:44), or a modification thereof, and having toll like receptor 5 (TLR5) binding. The immunomodulatory flagellin peptide also can have substantially the same amino acid sequence TQFSGVKVLAQDNTLTIQVGANDGETIDIDLKQINS QTLGLDTL (SEQ ID NO:45); EGALNEINNNLQRVRELAVQSANSTNSQSDLDSIQAEITQRLNEIDRVNG (SEQ ID NO:46) or MAQVINTNSLSLLTQNNLNKSQSALGTAIERLSSGLRINSAKDDAAGQAIANF TANIKGLTQASRNANDGISIAQTTEGALNEINNNLQRVRELAVQS (SEQ ID NO:47), or a modification thereof. Also provided is an immunomodulatory flagellin peptide having substantially the same amino acid sequence LQKIDAALAQVDTLRSDLGAVQNRFNSAITNL (SEQ ID NO:48), or a modification thereof, and having toll like receptor 5 (TLR5) binding. The immunomodulatory flagellin peptide also can have substantially the same amino acid sequence TLRSDLGAVQNRFNSAITNLGNTVNNLSS (SEQ ID NO:49) or EQAAKTTENPLQKIDAALAQVDTLRSDLGAVQNRFNSAITNLGNTVNNLSS (SEQ ID NO:50), or a modification thereof. Further provided is an immunomodulatory flagellin peptide having substantially the same amino acid sequence GALNEINNNLQRVRELAVQSANSTNSQSDLDSIQAE ITQ (SEQ ID NO:44) and substantially the same amino acid sequence LQKIDAALAQVDTLRSDLGAVQNRFNSAITNL (SEQ ID NO:48), or a modification thereof, and having toll like receptor 5 (TLR5) binding. Methods of using immunomodulatory flagellin peptides additionally are provided.

Toll-Like Receptor 5 Ligands And Methods Of Use

View page
US Patent:
20110008318, Jan 13, 2011
Filed:
Aug 24, 2009
Appl. No.:
12/546593
Inventors:
Alan Aderem - Seattle WA, US
Fumitaka Hayashi - North Quincy MA, US
Kelly D. Smith - Seattle WA, US
David M. Underhill - Seattle WA, US
Adrian Ozinsky - Seattle WA, US
International Classification:
A61K 39/395
A61K 39/00
C07K 14/195
C07K 14/52
C07K 14/00
C12N 1/20
A61P 37/04
US Classification:
4241301, 4241851, 530350, 530351, 530395, 435243
Abstract:
The invention provides an immunomodulatory flagellin peptide having at least about 10 amino acids of substantially the amino acid sequence GAVQNRFNSAIT, or a modification thereof, and having toll-like receptor 5 (TLR5) binding. Methods of inducing an immune response are also provided.

Toll-Like Receptor 5 Ligands And Methods Of Use

View page
US Patent:
20120269855, Oct 25, 2012
Filed:
Jul 26, 2011
Appl. No.:
13/191093
Inventors:
Alan Aderem - Seattle WA, US
Fumitaka Hayashi - North Quincy MA, US
Kelly D. Smith - Seattle WA, US
David M. Underhill - Seattle WA, US
Adrian Ozinsky - Seattle WA, US
Assignee:
University of Washington - Seattle WA
The Institute For Systems Biology - Seattle WA
International Classification:
A61K 39/39
C07K 14/21
C07K 14/195
C07K 14/24
C07K 14/255
A61P 31/04
C07K 14/25
C07K 14/20
C07K 14/32
C07K 14/33
A61K 39/02
A61P 37/04
C07K 14/28
C07K 14/245
US Classification:
4242341, 530350, 4242821, 4241841
Abstract:
The invention provides methods to elicit an immune response with an immunomodulatory flagellin polypeptide having toll-like receptor 5 (TLR5) binding, and further comprising an ADCC targeting molecule.
Fumitaka Hayashi from Saddle River, NJ, age ~52 Get Report